Literature DB >> 19567497

Obstructive sleep apnea is common in idiopathic pulmonary fibrosis.

Lisa H Lancaster1, Wendi R Mason2, James A Parnell3, Todd W Rice1, James E Loyd1, Aaron P Milstone1, Harold R Collard4, Beth A Malow5.   

Abstract

BACKGROUND: From 1984 to 2006, studies of sleep in patients with interstitial lung disease revealed disturbed sleep, frequent nocturnal desaturations, nocturnal cough, and obstructive sleep apnea (OSA). Our goal was to analyze OSA in an outpatient population of stable patients with idiopathic pulmonary fibrosis (IPF).
METHODS: Patients with IPF who had been followed up in the Vanderbilt Pulmonary Clinic were asked to participate. All patients were given a diagnosis of IPF by the 2000 American Thoracic Society consensus statement criteria. Subjects completed an Epworth sleepiness scale (ESS) questionnaire and a sleep apnea scale of sleep disorders questionnaire (SA-SDQ) before undergoing nocturnal polysomnography (NPSG). OSA was defined as an apnea-hypopnea index (AHI) of > 5 events per hour.
RESULTS: Fifty subjects enrolled and completed a NPSG. The mean age was 64.9 years, and the mean BMI was 32.3. OSA was diagnosed in 88% of subjects. Ten subjects (20%) had mild OSA (AHI, 5 to 15 events per hour), and 34 subjects (68%) had moderate-to-severe OSA (AHI, > 15 events per hour). Only 6 subjects (12%) had a normal AHI. One patient was asymptomatic as determined by ESS and SA-SDQ, but had an AHI of 24 events per hour. The sensitivity of the ESS was 75% with a specificity of 15%, whereas the SA-SDQ had a sensitivity of 88% with a specificity of 50%. BMI did not correlate strongly with AHI (r = 0.30; p = 0.05).
CONCLUSIONS: OSA is prevalent in patients with IPF and may be underrecognized by primary care providers and specialists. Neither ESS nor SA-SDQ alone or in combination was a strong screening tool. Given the high prevalence found in our sample, formal sleep evaluation and polysomnography should be considered in patients with IPF.

Entities:  

Mesh:

Year:  2009        PMID: 19567497      PMCID: PMC2775994          DOI: 10.1378/chest.08-2776

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  34 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

Review 2.  Epidemiology of obstructive sleep apnea: a population health perspective.

Authors:  Terry Young; Paul E Peppard; Daniel J Gottlieb
Journal:  Am J Respir Crit Care Med       Date:  2002-05-01       Impact factor: 21.405

3.  A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis.

Authors:  M Clark; B Cooper; S Singh; M Cooper; A Carr; R Hubbard
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

4.  Echocardiographic determination of mean pulmonary artery pressure.

Authors:  Amr E Abbas; F David Fortuin; Nelson B Schiller; Christopher P Appleton; Carlos A Moreno; Steven J Lester
Journal:  Am J Cardiol       Date:  2003-12-01       Impact factor: 2.778

Review 5.  Obstructive sleep apnea and cardiovascular disease.

Authors:  James M Parish; Virend K Somers
Journal:  Mayo Clin Proc       Date:  2004-08       Impact factor: 7.616

6.  Studies of oxygenation during sleep in patients with interstitial lung disease.

Authors:  P T Bye; F Issa; M Berthon-Jones; C E Sullivan
Journal:  Am Rev Respir Dis       Date:  1984-01

7.  Breathing during sleep in patients with interstitial lung disease.

Authors:  R Perez-Padilla; P West; M Lertzman; M H Kryger
Journal:  Am Rev Respir Dis       Date:  1985-08

8.  Obstructive sleep apnea in epilepsy patients: the Sleep Apnea scale of the Sleep Disorders Questionnaire (SA-SDQ) is a useful screening instrument for obstructive sleep apnea in a disease-specific population.

Authors:  Kevin J Weatherwax; Xihong Lin; Mary L Marzec; Beth A Malow
Journal:  Sleep Med       Date:  2003-11       Impact factor: 3.492

Review 9.  The role of gastroesophageal reflux in idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu
Journal:  Am J Med       Date:  2003-08-18       Impact factor: 4.965

10.  Sleep quality and associated daytime consequences in patients with idiopathic pulmonary fibrosis.

Authors:  C Mermigkis; E Stagaki; A Amfilochiou; V Polychronopoulos; P Korkonikitas; D Mermigkis; M Bregou; N Kouris; D Bouros
Journal:  Med Princ Pract       Date:  2008-12-04       Impact factor: 1.927

View more
  86 in total

1.  Commentary on How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Mermigkis C. et al.

Authors:  Karl-Heinz Ruhle
Journal:  Sleep Breath       Date:  2010-03-16       Impact factor: 2.816

2.  Sleep-disordered breathing and idiopathic pulmonary fibrosis--is there an association?

Authors:  T Reid; M Vennelle; M McKinley; P A MacFarlane; N Hirani; A J Simpson; Renata L Riha
Journal:  Sleep Breath       Date:  2015-02-10       Impact factor: 2.816

3.  Can we predict the survival of idiopathic pulmonary fibrosis patients? Sleep must be re-appreciated.

Authors:  Paschalis Steiropoulos
Journal:  J Clin Sleep Med       Date:  2013-06-15       Impact factor: 4.062

4.  Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis.

Authors:  Likurgos Kolilekas; Effrosyni Manali; Katerina A Vlami; Panagiotis Lyberopoulos; Christina Triantafillidou; Konstantinos Kagouridis; Katerina Baou; Sotirios Gyftopoulos; Konstantinos N Vougas; Anna Karakatsani; Manos Alchanatis; Spyros Papiris
Journal:  J Clin Sleep Med       Date:  2013-06-15       Impact factor: 4.062

Review 5.  Management of interstitial lung disease associated with connective tissue disease.

Authors:  Stephen C Mathai; Sonye K Danoff
Journal:  BMJ       Date:  2016-02-24

6.  Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis.

Authors:  Charalampos Mermigkis; Izolde Bouloukaki; Katerina Antoniou; Georgios Papadogiannis; Ioannis Giannarakis; Georgios Varouchakis; Nikolaos Siafakas; Sophia E Schiza
Journal:  Sleep Breath       Date:  2014-07-16       Impact factor: 2.816

7.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

8.  CPAP treatment in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea--therapeutic difficulties and dilemmas.

Authors:  Charalampos Mermigkis; Demetrios Mermigkis; Georgios Varouchakis; Sophia Schiza
Journal:  Sleep Breath       Date:  2011-01-09       Impact factor: 2.816

9.  CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep?

Authors:  Charalampos Mermigkis; Izolde Bouloukaki; Katerina M Antoniou; Demetrios Mermigkis; Kostas Psathakis; Ioannis Giannarakis; Georgios Varouchakis; Nikolaos Siafakas; Sophia E Schiza
Journal:  Sleep Breath       Date:  2013-02-06       Impact factor: 2.816

Review 10.  New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.

Authors:  Neil Ahluwalia; Barry S Shea; Andrew M Tager
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.